Eileen O'Reilly (MSKCC) Highlighting panc ca: PIII CONKO-005 trial, Gemcitabine +/- Erlotinib: not meaningful, no DFS OS improvmnt #ASCO15

9:02am June 1st 2015 via Hootsuite